Figure 1.
Metal-based anticancer drugs that primarily target DNA. (a) Pt(iv) complexes that deliver cisplatin and two equivalents of estradiol (1) and the GST inhibitor ethacrynic acid (2) after activation. (b) Photolabile platinum diazide complexes 4 and 5 demonstrate good cytotoxicity upon irradiation. (c) Typical, cytotoxic examples of the ruthenium- and osmium-arene family of complexes.